SCHEMBL9938547

SCHEMBL9938547

CCC(=O)Oc1ccc2c(ccc3c4c(ccc32)C=CC4)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 4/20 0.40
ACHE P22303 2/20 0.39
KMT2A Q03164 5/20 0.38
GLA P06280 3/20 0.38
GAA P10253 3/20 0.38
PDGFRB P09619 2/20 0.38
PDGFRA P16234 2/20 0.38
HPGD P15428 2/20 0.38
MAPK1 P28482 2/20 0.38
HSD17B10 Q99714 2/20 0.38
USP2 O75604 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
ESR1 P03372 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HIF1A Q16665 2/20 0.38
RECQL P46063 1/20 0.38
ELANE P08246 1/20 0.35
HTR1A P08908 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23199818 0.88 HTR1A (0.35) KDM4EALDH1A1KMT2AGLAGAA
SCHEMBL9938199 0.87 PDGFRB (0.41) KDM4EALDH1A1KMT2AGLAGAA
SCHEMBL30645497 0.87 KMT2A (0.42) KDM4EALDH1A1KMT2AGLAGAA
Hydrochloric Acid SCHEMBL23199823 0.86 PDGFRB (0.40) KDM4EALDH1A1KMT2AGLAGAA
SCHEMBL668901 0.86 CA12 (0.41) KDM4EALDH1A1KMT2AGLAGAA
SCHEMBL996026 0.86 CA12 (0.41) KDM4EALDH1A1KMT2AGLAGAA
SCHEMBL9938270 0.85 ACHE (0.40) ACHERAB9A
SCHEMBL9938274 0.83 ELANE (0.38) ALDH1A1HPGDHSD17B10SMN1; SMN2ELANE
SCHEMBL9938614 0.83 MEN1 (0.42) KMT2AELANEHTR1DHTR1B
SCHEMBL19253296 0.81 NCEH1 (0.30) KMT2ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651916-A2 C-17-HETEROARYL STEROIDAL COMPOUNDS AS INHIBITORS OF CYP11B, CYP17, AND/OR CYP21 BioMarin Pharmaceutical Inc. (US) 2013-10-23 EP disclosed
WO-2012083112-A2 CYP11B, CYP17, AND/OR CYP21 INHIBITORS BIOMARIN PHARMACEUTICAL INC. (US) 2012-06-21 WO disclosed